title: Transcatheter aortic valve implantation for degenerative aortic valve regurgitation long after heart transplantation.
abstract: Transcatheter aortic valve implantation (TAVI) has become a feasible therapeutic option for the management of high-risk patients with severe degenerative aortic stenosis. Recently it has been extended to high-risk patients with severe aortic regurgitation. Degenerative aortic valve disease is generally uncommon in heart transplant recipients. We report the case of a 75-year-old man in whom severe degenerative aortic regurgitation developed 14 years after heart transplantation (HTx). Because of multiple comorbidities and high surgical risk, TAVI was preferred. A 29-mm CoreValve prosthesis (Medtronic Inc, Minneapolis, MN) was successfully implanted using a transfemoral approach.
authors.affiliation: Department of Cardiology, Santa Maria della Misericordia Hospital, Udine, Italy.
authors.forename: Davide
authors.initials: D
authors.lastname: Zanuttini
authors.forename: Ilaria
authors.initials: I
authors.lastname: Armellini
authors.forename: Teodoro
authors.initials: T
authors.lastname: Bisceglia
authors.forename: Leonardo
authors.initials: L
authors.lastname: Spedicato
authors.forename: Guglielmo
authors.initials: G
authors.lastname: Bernardi
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Muzzi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Proclemer
authors.forename: Ugolino
authors.initials: U
authors.lastname: Livi
mesh_terms: D000368:Aged; D001021:Aortic Valve / Q000601:surgery*; D001022:Aortic Valve Insufficiency / Q000601:surgery*; D002404:Catheterization; D016027:Heart Transplantation; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000601:surgery*; D012720:Severity of Illness Index; D013997:Time Factors
keywords: 35